MUDr. Jitka Hausnerová
Assistant professor, Department of Pathology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2799 |
---|---|
E‑mail: |
Total number of publications: 73
2023
-
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes
Translational research, year: 2023, volume: 260, edition: Ocotber 2023, DOI
-
Molekulární testování karcinomu endometria - analýza prvních zkušeností z klinické praxe
Klinická onkologie, year: 2023, volume: 36, edition: 3, DOI
-
Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories
Modern Pathology, year: 2023, volume: 36, edition: 1, DOI
-
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance
PATHOLOGY, year: 2023, volume: 55, edition: 6, DOI
-
The Combined Genomic and Immunohistochemical Tumor Profiling As a Tool of Precision Oncology Approach In the Real-World Cohort Of Patients With Gynecological Cancers
Year: 2023, type: Conference abstract
-
Význam nového prediktivního markeru Schlafen 11 u pacientek s karcinomem ovaria léčených chemoterapií založené na platinovém derivátu – výsledky pilotní analýzy
Klinická onkologie, year: 2023, volume: 36, edition: Suppl 1, DOI
2022
-
2022-RA-1304-ESGO Molecular testing of endometrial carcinoma brings growing opportunity to identify patients with inherited risk of cancer
Year: 2022, type: Conference abstract
-
Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?
Cancers, year: 2022, volume: 14, edition: 10, DOI
-
Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?
Cancers, year: 2022, volume: 14, edition: 1, DOI
-
External validation study of endometrial cancer preoperative risk stratification model (ENDORISK)
Frontiers in Oncology, year: 2022, volume: 12, edition: August 2022, DOI